Bone Biologics enters ATM equity offering agreement with H.C. Wainwright for up to $1.14M

Bone Biologics Corp

Entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC to sell common stock shares from time to time.
Aggregate market value of shares eligible for sale under the ATM prospectus supplement is $1,143,121.
Commission to Wainwright at 3.0% of gross proceeds; Company to reimburse expenses up to $100,000 plus due diligence fees.
Offering terminates upon sale of $1.14M or termination by either party; Company not obligated to sell any shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.